Pancragen
Lys-Glu-Asp-Trp · KEDW · Pancreas bioregulator
Think of it as a personal trainer for your pancreas.
Pancragen is like a pep talk for your pancreas. It's a lab-created peptide that aims to boost your pancreas's natural functions by slipping into cells and turning on certain genes. This might help the pancreas do its job better, like managing blood sugar levels more efficiently.
Researchers have been poking around in labs and have noted some promising signs. In cell studies, Pancragen seemed to encourage genes linked to insulin production to get to work. There's also some chatter from rodent studies about how it could potentially help with glucose management as they age.
However, it's worth noting that while the science is intriguing, it's mostly early-stage and not FDA-approved. That means it's still in the "let's see where this goes" phase rather than a proven game-changer.
Who it's for
- Health enthusiasts curious about cutting-edge research.
- Biohackers interested in potential metabolic boosts.
- People intrigued by regenerative medicine trends.
Probably not for you if…
- Those expecting an FDA-approved solution.
- People looking for immediate, guaranteed results.
- Anyone uncomfortable with experimental compounds.
Editorial summary for research context · Not medical advice
Mechanism of Action
Pancragen is a synthetic tetrapeptide (Lys-Glu-Asp-Trp) designed as a pancreas-specific bioregulator. Khavinson-group research proposes that short peptides penetrate cell membranes, enter the nucleus, and modulate tissue-specific gene expression — including markers relevant to pancreatic islet cell function and exocrine tissue. Not FDA-approved. Preclinical and limited clinical data from Khavinson group.
Researched Benefits
Pancreatic islet gene-expression research
Khavinson-lab cell-culture studies report modulation of gene expression relevant to insulin biosynthesis and pancreatic beta-cell markers.
- [Khavinson et al. 2014]
Preclinical metabolic-aging research
Russian-language studies have examined effects on glucose-tolerance endpoints in aged rodents.
- [Ryzhak et al. 2011]
Research Protocols
The following dosing ranges have appeared in published research protocols. Presented for informational purposes only — not a recommendation for human use.
Intranasal research protocol
- Dosage
- 100 mcg
- Frequency
- once daily
- Timing
- morning
- Cycle
- 3 weeks
Khavinson-group protocols have typically used 20-30 day cycles.
Reported Side Effects
- No significant adverse events reported in published Khavinson-group studies
- Transient local irritation with intranasal administration
- Long-term human safety data limited
Contraindications
- Pregnancy and lactation (no safety data)
- Active pancreatic malignancy (theoretical concern)
- Individual hypersensitivity to peptide components
Stacking Partners
Peptides commonly paired with Pancragen in published research and protocol write-ups.
Vendor Pricing
Stacked earns a commission on purchases via these links. It does not influence our Trust Scores.
Top Videos
Curated from YouTube — refreshed weekly. Stacked doesn't host or endorse external content.
8:257 Silent Signs of Pancreatic Cancer
Dr. Eric Berg DC
768.2K views · 8:25 · 1 year ago
6:04Doctor Explains 20 Most Powerful Peptides
This Is Not Covered - Dr. Ashley Froese
472.6K views · 6:04 · 7 months ago
5:59Peptides for Kidney & Liver Health
Ageless Future
182.8K views · 5:59 · 3 years ago
13:08My Favorite Bioregulator Peptide for Liver Support - Ovagen
Elwin Robinson
6.5K views · 13:08 · 2 years ago
6:31RESTORE your Kidneys with the Peptide Bioregulator Pielotax
The Enhanced Man
3.6K views · 6:31 · 1 year ago
Research Papers
Peptide regulation of the pancreatic gland: a Khavinson-group review
Khavinson VKh, et al. · Advances in Gerontology · 2014
Pancragen and experimental models of pancreatic aging
Ryzhak GA, et al. · Advances in Gerontology · 2011